Immune Modulation Ability of Hepcidin from Teleost Fish

Area of Science:

• Immunology
• Molecular Biology
• Aquaculture

Background:

• Antimicrobial peptides (AMPs) are crucial for innate immunity and defense responses.
• Previous research established the antimicrobial activity and protective role of synthetic hepcidin (hep20) in fish.
• Host defense peptides (HDPs) in higher vertebrates exhibit immunomodulatory functions beyond antimicrobial activity.

Purpose of the Study:

• To investigate the immunomodulatory potential of synthetic hepcidin (hep20) in teleost fish.
• To evaluate hep20's effects on pro- and anti-inflammatory cytokine expression in vitro and in vivo.
• To explore the structural basis for hep20's immunomodulatory capabilities.

Main Methods:

• In vitro studies using a rainbow trout monocyte/macrophage cell line (RTS-11) to assess cytokine induction.
• In vivo studies in European sea bass juveniles involving intraperitoneal injections of hep20.
• Quantification of cytokine mRNA (IL-10, IL-1β, TNFα) in immune tissues (head kidney, spleen, gut) at various time points post-injection.
• Bioinformatics analysis to compare hep20 structure with known immunomodulatory domains.

Main Results:

• Hep20 was internalized by RTS-11 cells and induced expression of IL-10, IL-1β, and TNFα at both transcriptional and protein levels.
• In vivo, hep20 administration upregulated cytokine gene expression in European sea bass immune tissues, particularly the head kidney.
• Cytokine expression exhibited a cyclical pattern, increasing and then decreasing over 21 days post-injection.
• Bioinformatics analysis revealed hep20's structure resembles the immunomodulatory γ-core domain of cysteine-stabilized AMPs.

Conclusions:

• Synthetic hepcidin (hep20) possesses significant immunomodulatory functions in teleost fish, complementing its antimicrobial activity.
• Hep20's ability to regulate cytokine expression suggests a broader role as a host defense peptide in fish innate immunity.
• The structural similarity to known immunomodulatory domains provides a molecular basis for hep20's observed effects.